Michelle L. Basil - May 16, 2025 Form 4/A - Amendment Insider Report for HAEMONETICS CORP (HAE)

Role
EVP and General Counsel
Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Basil
Stock symbol
HAE
Transactions as of
May 16, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/13/2025, 04:26 PM
Date Of Original Report
May 20, 2025
Previous filing
May 19, 2025
Next filing
Jun 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Basil Michelle L EVP and General Counsel 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Ms. Basil 2025-06-13 0001699629

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +6.76K +23.72% 35.2K May 16, 2025 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Award $0 +14.6K $0.00 14.6K May 16, 2025 Common Stock 14.6K $70.31 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
F2 On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of RSUs awarded to be 5,689 instead of 6,755. This net increase of 1,066 RSUs, and the corresponding change in securities beneficially owned by the reporting person, will be reflected in future filings by the reporting person.
F3 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F4 This number includes unvested RSUs previously reported.
F5 On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of options awarded to be 12,317 instead of 14,626. This net increase of 2,309 options will be reflected in future filings by the reporting person.
F6 Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.